Benitec Biopharma Inc.: Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular Dys ...
Nano-X Imaging: When Will The Hockey Stick Growth Happen?
Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...
Yale Scientists Reprogram Genetic Code To Create Revolutionary Synthetic Organism
Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...
Wacker Chemie: Strong Market Position Amid Macro Headwinds
Wacker Chemie offers strong growth in semiconductors, solar, and biotech with a 60% upside. Click here to find out why WKCMF ...
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
Rebranding Invizyne Technologies, Inc to eXoZymes Inc.Changing NASDAQ ticker from IZTC to EXOZIntroducing but not trademarking “exozymes” as a ...
Creative Medical Technology Holdings, Inc.: Creative Medical Technology Reports Positive One-Year Results for AlloStem Type 2 Diabetes Program
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced ...
stocknews5d
3 Biotech Stocks Revolutionizing Healthcare
Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...